These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 36432422)

  • 21. Role of Aldosterone and Mineralocorticoid Receptor in Cardiovascular Aging.
    Gorini S; Kim SK; Infante M; Mammi C; La Vignera S; Fabbri A; Jaffe IZ; Caprio M
    Front Endocrinol (Lausanne); 2019; 10():584. PubMed ID: 31507534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.
    Jung UJ; Choi MS
    Int J Mol Sci; 2014 Apr; 15(4):6184-223. PubMed ID: 24733068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mineralocorticoid receptor: a new player controlling energy homeostasis.
    Kuhn E; Lombès M
    Horm Mol Biol Clin Investig; 2013 Sep; 15(2):59-69. PubMed ID: 25436733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adipocyte Mineralocorticoid Receptor.
    Infante M; Armani A; Marzolla V; Fabbri A; Caprio M
    Vitam Horm; 2019; 109():189-209. PubMed ID: 30678856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eplerenone prevented obesity-induced inflammasome activation and glucose intolerance.
    Wada T; Ishikawa A; Watanabe E; Nakamura Y; Aruga Y; Hasegawa H; Onogi Y; Honda H; Nagai Y; Takatsu K; Ishii Y; Sasahara M; Koya D; Tsuneki H; Sasaoka T
    J Endocrinol; 2017 Dec; 235(3):179-191. PubMed ID: 28855315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome.
    Maury E; Brichard SM
    Mol Cell Endocrinol; 2010 Jan; 314(1):1-16. PubMed ID: 19682539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aldosterone Production and Signaling Dysregulation in Obesity.
    Vecchiola A; Lagos CF; Carvajal CA; Baudrand R; Fardella CE
    Curr Hypertens Rep; 2016 Mar; 18(3):20. PubMed ID: 26838033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The renin-angiotensin system in adipose tissue and its metabolic consequences during obesity.
    Frigolet ME; Torres N; Tovar AR
    J Nutr Biochem; 2013 Dec; 24(12):2003-15. PubMed ID: 24120291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease.
    Fuster JJ; Ouchi N; Gokce N; Walsh K
    Circ Res; 2016 May; 118(11):1786-807. PubMed ID: 27230642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adipocyte-Mineralocorticoid Receptor Alters Mitochondrial Quality Control Leading to Mitochondrial Dysfunction and Senescence of Visceral Adipose Tissue.
    Lefranc C; Friederich-Persson M; Foufelle F; Nguyen Dinh Cat A; Jaisser F
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adipocyte Mineralocorticoid Receptor Activation Leads to Metabolic Syndrome and Induction of Prostaglandin D2 Synthase.
    Urbanet R; Nguyen Dinh Cat A; Feraco A; Venteclef N; El Mogrhabi S; Sierra-Ramos C; Alvarez de la Rosa D; Adler GK; Quilliot D; Rossignol P; Fallo F; Touyz RM; Jaisser F
    Hypertension; 2015 Jul; 66(1):149-57. PubMed ID: 25966493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mineralocorticoid Receptor Activation in Vascular Insulin Resistance and Dysfunction.
    Igbekele AE; Jia G; Hill MA; Sowers JR; Jia G
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mineralocorticoid receptors in the metabolic syndrome.
    Zennaro MC; Caprio M; Fève B
    Trends Endocrinol Metab; 2009 Nov; 20(9):444-51. PubMed ID: 19800255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nε-(carboxymethyl)lysine-receptor for advanced glycation end product axis is a key modulator of obesity-induced dysregulation of adipokine expression and insulin resistance.
    Gaens KH; Goossens GH; Niessen PM; van Greevenbroek MM; van der Kallen CJ; Niessen HW; Rensen SS; Buurman WA; Greve JW; Blaak EE; van Zandvoort MA; Bierhaus A; Stehouwer CD; Schalkwijk CG
    Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1199-208. PubMed ID: 24723555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adipose Tissue Inflammation and Pulmonary Dysfunction in Obesity.
    Palma G; Sorice GP; Genchi VA; Giordano F; Caccioppoli C; D'Oria R; Marrano N; Biondi G; Giorgino F; Perrini S
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adipokines mediate inflammation and insulin resistance.
    Kwon H; Pessin JE
    Front Endocrinol (Lausanne); 2013; 4():71. PubMed ID: 23781214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Adrenal Steroids on Regulation of Adipose Tissue.
    Infante M; Armani A; Mammi C; Fabbri A; Caprio M
    Compr Physiol; 2017 Sep; 7(4):1425-1447. PubMed ID: 28915330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity and metabolic syndrome: an inflammatory condition.
    Scarpellini E; Tack J
    Dig Dis; 2012; 30(2):148-53. PubMed ID: 22722429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intricacies of the endothelin system in human obesity: role in the development of complications and potential as a therapeutic target.
    Schinzari F; Cardillo C
    Can J Physiol Pharmacol; 2020 Sep; 98(9):563-569. PubMed ID: 32808824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocrine functions of adipose tissue.
    Waki H; Tontonoz P
    Annu Rev Pathol; 2007; 2():31-56. PubMed ID: 18039092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.